SCHEMBL27940468

SCHEMBL27940468

CCC(N)(O)c1ccc(CN)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 5/20 0.43
ABAT P80404 1/20 0.43
HRH3 Q9Y5N1 1/20 0.41
MAOB P27338 1/20 0.40
NOS3 P29474 2/20 0.39
NOS1 P29475 2/20 0.39
NOS2 P35228 2/20 0.39
PSIP1 O75475 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
NCOR2 Q9Y618 1/20 0.38
F10 P00742 1/20 0.38
F11 P03951 1/20 0.38
KIF11 P52732 1/20 0.37
TAAR1 Q96RJ0 2/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
KDM4E B2RXH2 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28444643 0.79 ABAT (0.43) LOXL2ABATHRH3NOS3NOS1
SCHEMBL18106924 0.78 MAPT (0.46) KIF11ESR1ESR2
SCHEMBL28049734 0.78 ESR1 (0.58) KIF11ESR1ESR2SMN1; SMN2
SCHEMBL2689524 0.77 LOXL2 (0.44) LOXL2ABATHRH3MAOBNOS3
Hydrochloric Acid SCHEMBL6463385 0.77 ESR1 (0.56) KIF11ESR1ESR2
SCHEMBL5085651 0.76 KCNN4 (0.46) KIF11TAAR1KDM4ESMN1; SMN2
SCHEMBL4825874 0.76 ABAT (0.48) LOXL2ABATHRH3MAOBNOS3
SCHEMBL42067 0.76 KCNN4 (0.46) KIF11TAAR1KDM4ESMN1; SMN2
SCHEMBL28065526 0.76 KCNN4 (0.46) KIF11TAAR1KDM4ESMN1; SMN2
SCHEMBL19941702 0.75 MAOB (0.43) LOXL2ABATHRH3MAOBNOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103588906-A Preparation method for 1-(4-methylphenyl)-1-propanol substituted 6-amino-beta-cyclodextrin derivative SHANGHAI RUICHUANG MEDICAL TECHNOLOGY CO LTD 2014-02-19 CN disclosed